Home | Careers | Contact Us | Sitemap 
   Other Country Sites Search
Newsroom
Generic FAQs
 


Home > Newsroom  
 September 2009
 
 Day : 2
Ranbaxy Launches Authorized Generic Version Of Rocaltrol®
 
 
 August 2009
 
 Day : 24
Ranbaxy Receives Final Approval To Manufacture And Market Glycopyrrolate Tablets
 
 
 Day : 11
Ranbaxy Receives Final Approval To Market Sumatriptan Succinate Tablets
 
 
  May 2009
 
 Day : 1
Ranbaxy Voluntarily Recalls Nitrofurantoin Capsules In The U.S.
 
 
 March 2009
 
 Day : 5
Ranbaxy Secures Final FDA Approval For Quinapril Hydrochloride + Hydrochlorothiazide Tablets
 
 
 February 2009
 
 Day : 26
Press Statement
 
 
 September 2008
 
 Day : 17
Ranbaxy Laboratories, Ltd., Retains former New York City Mayor Rudy Giuliani to lead team in resolution of issues raised by U. S. Food & Drug Administration
 
 
 July 2008
 
 Day : 28
Ranbaxy launches Omeprazole 40 mg capsules
 
 
 June 2008
 
 Day : 25
Ranbaxy gains tentative approval to manufacture and market Valganciclovir Hydrochloride tablets
 
 Day : 18
Ranbaxy and Pfizer settle Lipitor Litigation worldwide
 
 Day : 11
Ranbaxy to bring in Daiichi Sankyo Company Limited as Majority Partner
 
 
 April 2008
 
 Day : 15
Ranbaxy and AstraZeneca reach agreement in esomeprazole patent litigation
 
 
 February 2008
 
 Day : 7
Ranbaxy receives tentative approval to manufacture and market Esomeprazole Magnesium dr capsules
 
 Day : 6
Ranbaxy gains approval to manufacture and market Cefuroxime axetil for oral suspension
 
 
 November 2007
 
 Day : 8
Ranbaxy and Astellas/Boehringer Ingelheim Enter Into an Agreement to Resolve Tamsulosin U.S. Patent Litigation
 
 
October 2007
 
Day : 29
Ranbaxy Receives Tentative Approval for Valsartan Tablets
 
Day : 2
Ranbaxy First to Gain Approval to Manufacture and Market Clarithromycin for Oral Suspension, USP
 

Media Contacts

Chuck Caprariello
Vice President, Corporate Communications and Government Affairs
Phone: (609)720-5615
chuck.caprariello@ranbaxy.com

Edwige Buteau
Phone: (212) 994-7517
edwige.buteau@rfbinder.com